|
Post by sevenofnine on Jun 25, 2022 16:19:11 GMT -5
Okay folks I take one for the team LOL! do it my duty as your fav internatioal news diva I could handle it I be tired I be good after A DAY LOL! CNN)Two Pfizer and BioNTech Covid-19 vaccine boosters updated to target the Omicron variant show a substantially higher immune response than the current Covid-19 vaccine, the companies said Saturday. The companies tested a vaccine that targets Omicron BA.1 subvariant and bivalent booster -- which targets two strains -- that includes the current Pfizer/BioNTech Covid-19 vaccine and a vaccine candidate that targets Omicron. The study looked at two different dose levels -- 30 micrograms and 60 micrograms -- in more than 1,200 adults age 56 and older. The current primary and booster dosage for this age group is 30 micrograms. The study showed that, across both dose levels, a fourth booster with the Omicron-modified vaccine candidates resulted in a substantially higher immune response against the variant. One month www.cnn.com/2022/06/25/health/pfizer-booster-results/index.html
|
|